Over 100 Total Lots Up For Auction at Two Locations - WA 11/05, PA 11/06

Penn Medicine and IBA present third annual course on proton therapy

Press releases may be edited for formatting or style | November 02, 2016 Rad Oncology Proton Therapy
Louvain-La-Neuve, Belgium, Philadelphia, Pennsylvania, November 2, 2016 - IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions and the department of Radiation Oncology in the Perelman School of Medicine at the University of Pennsylvania (Philadelphia, PA) in partnership with OncoLink, proudly present the Third Annual Course on Proton Therapy: Past Lessons and Future Prospects, on November 18-20 in Philadelphia. This unique opportunity presents medical professionals and administrators interested in proton therapy with an intensive three-day proton therapy immersion program at Penn Medicine. After two successful years, this 3rd edition course will attract an even larger number of attendees for the third edition.

The course offers in-depth insights to the practical application of proton therapy for administrators, clinicians and medical physicists from cancer centers considering establishing proton therapy. Andrew Dike, Service Offering Manager at IBA, highlights why this unique course is so valuable. "There is a real surge of interest in proton therapy within the global radiation oncology community, and as we have seen, and an increase in proton therapy centers being constructed worldwide. This course provides a dynamic forum to better understand what it takes to make proton therapy a reality in a health system or cancer center. IBA is proud to be a part of such an important event that helps the field of proton therapy grow to eventually reach all patients who would benefit from this treatment option.”

Over the past two years, the course has received excellent feedback from attendees stating that the material presented is practical and useful in daily operations. Anders Navrsted Pedersen, Clinical Director of the Radiotherapy Program at Copenhagen University Hospital (Rigshospitalet) in Denmark commented: "I attended the course in order to advise patients, refer patients, prepare comparison dose plans and prepare for proton therapy in my own center".

Sanford Katz, MD,radiation oncologist at the Willis-Knighton Cancer Center in Shreveport, LA: “I came back from the seminar with interesting new views which we are now considering for our treatment planning and program. All the speakers were approachable and encouraged us to contact them in case of questions, which really gave the feeling that if you were to embark on this big journey, you become part of and are backed up by a community of like-minded peers.”

You Must Be Logged In To Post A Comment